title: Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction.
abstract: Protein expression profiles in rat bladder smooth muscle were compared between animal models of streptozotocin-induced diabetes mellitus (STZ-DM) and age-matched controls at 1 week and 2 months after induction of hyperglycemia with STZ treatment. At each time point, protein samples from four STZ-DM and four age-matched control rat bladder tissues were prepared independently and analyzed together across multiple DIGE gels using a pooled internal standard sample to quantify expression changes with statistical confidence. A total of 100 spots were determined to be significantly changing among the four experimental groups. A subsequent mass spectrometry analysis of the 100 spots identified a total of 56 unique proteins. Of the proteins identified by two-dimensional DIGE/MS, 10 exhibited significant changes 1 week after STZ-induced hyperglycemia, whereas the rest showed differential expression after 2 months. A network analysis of these proteins using MetaCore suggested induction of transcriptional factors that are too low to be detected by two-dimensional DIGE and identified an enriched cluster of down-regulated proteins that are involved in cell adhesion, cell shape control, and motility, including vinculin, intermediate filaments, Ppp2r1a, and extracellular matrix proteins. The proteins that were up-regulated include proteins involved in muscle contraction (e.g. Mrlcb and Ly-GDI), in glycolysis (e.g. alpha-enolase and Taldo1), in mRNA processing (e.g. heterogeneous nuclear ribonucleoprotein A2/B1), in inflammatory response (e.g. S100A9, Annexin 1, and apoA-I), and in chromosome segregation and migration (e.g. Tuba1 and Vil2). Our results suggest that the development of diabetes-related complications in this model involves the down-regulation of structural and extracellular matrix proteins in smooth muscle that are essential for normal muscle contraction and relaxation but also induces proteins that are associated with cell proliferation and inflammation that may account for some of the functional deficits known to occur in diabetic complications of bladder.
authors.affiliation: Case Center for Proteomics, Case Western Reserve University, Cleveland, Ohio 44106, USA.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Yohannes
authors.forename: Jinsook
authors.initials: J
authors.lastname: Chang
authors.forename: George J
authors.initials: GJ
authors.lastname: Christ
authors.forename: Kelvin P
authors.initials: KP
authors.lastname: Davies
authors.forename: Mark R
authors.initials: MR
authors.lastname: Chance
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000032:analysis* / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000139:chemically induced / Q000150:complications*; D006943:Hyperglycemia / Q000209:etiology / Q000378:metabolism; D008297:Male; D020543:Proteome / Q000032:analysis; D040901:Proteomics; D051381:Rats; D011916:Rats, Inbred F344; D013311:Streptozocin; D013997:Time Factors; D001745:Urinary Bladder Diseases / Q000209:etiology* / Q000378:metabolism*
chemical_list: D015415:Biomarkers; D020543:Proteome; D013311:Streptozocin